Drug class
Allergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Folate Analog [EPC]; Folic Acid [CS]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Plant Proteins [CS]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin D [CS]; Vitamin D [EPC]
Uses
Indications and Usage: For the dietary management of menopausal symptoms and the support of overall health during the menopausal phase.
Boxed warning
Warnings: Tell your doctor if you have: kidney problems, thyroid disease. This medication should be used as directed during pregnancy or while breast-feeding. Consult your doctor. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient. Precautions Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia, since folate may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
Contraindications
Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients. Menatrolâ„¢ Capsules are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D, and hypervitaminosis D.
Overdose
Overdosage: In case of overdose, seek medical attention immediately. Symptoms may include nausea, vomiting, or diarrhea.
Drug interactions
Drug Interactions: Consult with a licensed healthcare practitioner before use if taking prescription medications, especially those affecting bone health or hormonal therapies.
Dosage & administration
Dosage and Administration: Take one (1) capsule daily or as directed by a licensed healthcare practitioner.
Side effects
Adverse Reactions: Possible side effects may include gastrointestinal upset. If any side effects persist or worsen, discontinue use and consult a physician.